Are you sure you want to hide the widget forever? If you need it back, please clear your cookies.
Content
Colors
Navigation
English (United States)
Accessibility Statement
Our Commitment to Accessibility
We are committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards to help users with various disabilities access our website effectively.
Compliance Status
Our website strives to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA standards. We also aim to be compliant with the Americans with Disabilities Act (ADA) and the European Accessibility Act requirements. These guidelines and regulations explain how to make web content more accessible to people with a wide range of disabilities. We acknowledge that some aspects of our website may not yet achieve full compliance, and we are actively working to address these areas.
Accessibility Features Available
Our website implements the Accessibly App, which provides a variety of tools to enhance website accessibility:
Visual Adjustments
Bigger Text: Increase text size up to 3x for better readability (WCAG 2.1/1.4.4)
Bigger Cursor: Enhanced cursor visibility for easier navigation
Color Adjustments: Invert colors, adjust contrast, brightness, and saturation
Grayscale Mode: Convert website to grayscale for users with visual impairments
Hide Images: Reduce visual distractions for easier reading
Reading and Navigation Aids
Reading Line: Adds a guide line to help follow text
Reading Mask: Places a mask over text to isolate lines and enhance focus
Readable Fonts: Converts to highly legible fonts for better comprehension
Highlight Links: Makes links more prominent for easier navigation
Dyslexic Fonts: Special typography for users with dyslexia
Page Structure: Simplified layout options for easier navigation
Assistive Technologies
Keyboard Navigation: Full website control using keyboard (Tab, Shift+Tab, Enter)
Alt Text for Images: AI-generated image descriptions where manual ones aren't provided
Read Page Aloud: Text-to-speech functionality
Stop Animations: Pause motion content for users with vestibular disorders
Limitations and Feedback
Despite our best efforts to ensure accessibility, there may be some limitations. Content provided by third parties, user-generated content, or certain legacy pages may not be fully accessible. We are continuously working to improve our website's accessibility.
We welcome your feedback on the accessibility of our website. If you encounter any barriers or have suggestions for improvement, please contact us. We are committed to addressing these issues promptly.
Technical Information
The accessibility features on this website are provided through the Accessibly App, which utilizes several technologies including HTML, CSS, JavaScript, and various frameworks to enhance accessibility. Our implementation strives to be compatible with major screen readers and assistive technologies.
Legal Disclaimer
While we strive to adhere to WCAG 2.1 Level AA standards and provide accessible content, we cannot guarantee that our website will be accessible to all users under all circumstances. This website is provided 'as is' without any representations or warranties, express or implied.
In no event shall we be liable for any damages arising from or related to:
Inability to access or use the website
Any alleged non-compliance with accessibility laws or regulations
Any disruption or errors in the functionality of accessibility features
By using this website, you agree to hold us harmless from any claims related to website accessibility issues. We are committed to addressing accessibility barriers in good faith but cannot guarantee immediate resolution in all cases.
Contact Us
If you have any questions about our accessibility efforts or encounter any barriers while using our website, please contact us.
Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
July 17, 2023 12:00 pm ETEstimated Read Time: 5 Minutes
The Senate Intelligence Committee has passed a bill that allows intelligence agencies like the CIA and NSA to accept applicants who have marijuana-use history. The FY24 Intelligence Authorization Act was approved after it secured a unified vote of 17-0 on June 14, 2023. Marijuana has been legalized for recreational use in 23 U.S. states, including Washington, D.C. This bill is a progressive step as it clearly states that intelligence organizations cannot deny aspirants security clearance because they have used cannabis in the past.
The legislation was sponsored by Sen. Ron Wyden (D), a senior member of the Intelligence Committee. According to him, ‘This bill includes bipartisan legislation reforming the country’s broken classification and declassification system. In a press release, he further explained, “The bill also includes my provision to ensure that cannabis use will not disqualify intelligence community aspirants from serving their country. It’s a commonsense change to ensure the IC (Intelligence Community) can recruit the most capable people possible. Finally, the bill includes critically important provisions to protect Intelligence Community whistleblowers.”
What Happened Back in 2022?
Earlier in June 2022, Wyden had filed an amendment to prevent unfair employment restrictions because of past or current cannabis use in all federal agencies. He called it a common-sense change to ensure the IC can recruit the most capable people possible. Sen. Martin Heinrich and Sen. Kristen from New Mexico and New York, respectively, also supported the bill.
The legislation “prohibited any Federal agency from denying or revoking an individual’s eligibility for access to classified information solely because of the past or present use of cannabis.” A second-degree revision reduced it to only intelligence communities like the Federal Bureau of Intelligence (FBI), the National Security Agency (NSA), and the Central Intelligence Agency (CIA). The initial “past or present use” text was also modified to “pre-employment.”
In September 2022, Wyden’s motion was opposed by Sen. Chuck Grassley and Sen. John Cornyn. Because of this opposition, it was not included in the National Defense Authorization Act (NDAA).
More Information About the Legislation
The committee stated that the details of the newly reformed bill won’t be accessible until it has been approved by legislative counsel. However, Wyden hinted that what was passed is similar to 2022’s narrowly tailored proposal. It seems that the bill met a progressive stance within the Senate. The committee chair, Mark Warner (D), mentioned that the legislation would boost the efforts to amend the security clearance process. He also noted that it would enable the intelligence community to employ diverse and skilled personnel to help tackle emerging issues.
At a March committee hearing, Wyden had earlier discussed the situation with Avril Haines, the Director of National Intelligence (DNI). She stated, “We recognize, frankly, that many states have legalized or decriminalized marijuana use and wanted to be sure that we’re not disqualifying people solely for that purpose in that context.” She further explained that marijuana use in a legal state should not be the only disqualifying basis. She also emphasized the necessity of a holistic approach in assessing candidates.
See If You Qualify For Medical Marijuana -Select Your State!
Past Progress
National security personnel has severally mentioned in the past that the lifetime restriction on marijuana use has limited the number of qualified applicants in their agencies. And that the need to take in tech and cybersecurity experts is a priority for the community.
In 2021, the Federal Bureau of Intelligence (FBI) expressed its concern and loosened its hiring guidelines relative to cannabis use. The update stated that “Candidates cannot have used marijuana or cannabis in any form (natural or synthetic) and in any location (domestic or foreign) within the one (1) year preceding the date of their application for employment.” The revision downgraded the initial three-year withdrawal period to one year.
With more people being open to legalization than ever, there have been positive modifications to past restrictions. The U.S. Secret Service (USSS) revised its employment policies. Candidates of any age who have used cannabis are eligible within 12 months of their last consumption.
The Federal Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF) also updated its marijuana rules for applicants. Persons who have sold or manufactured cannabis in obedience to state laws while holding a ‘position of public responsibility’ are eligible for recruitment.
In 2020, the CIA voiced its stance that using marijuana and other drugs doesn’t necessarily make a person bad or unworthy. Also in 2021, Biden’s administration granted waivers to certain workers who acknowledge past marijuana use.
Moving Forward
A recent study revealed that 30% of federal job aspirants between ages 18 and 30 have either withdrawn or declined their applications because of the strict cannabis restriction needed for security clearance. However, with the FY24 Intelligence Authorization Act in motion, things are expected to change.
The legislation is waiting to pass through the House Intelligence Committee and the Senate floor for approval.
Mary Ekundayo is a passionate cannabis writer and entrepreneur with a love for all things literary. When she's not creating content, you can find Mary lost in the pages of a captivating book or meditating to set the tone for her day.
Mental health is crucial to our well-being. The National Institute of Mental Health (NIMH) estimates that more than one in five U.S. adults is currently living with a mental health condition. The effort to destigmatize the conversations around mental health is recognized from Mental Health Awareness Month in May to World Suicide Prevention Day in…
For years, celebrities looking for their next investment opportunity or endorsement deal have flocked to the alcohol industry. With its huge market value ($2,313.2 billion in 2023), expected growth (Fortune Business Insights predicts it will top $5,716.2 billion by 2032), and abundance of brands eager to differentiate themselves from a sea of similar products, the…
As cannabis use and accessibility grow nationwide, many universities have established pathways to study the business and science of the plant. Students can research cannabis and its many compounds, pharmacology, cultivation, business, marketing, public policy, and so much more. Beyond cannabis-specific schools like Oaksterdam University and THC University, aspiring cannabis professionals have many options to…
Cannabis is (nearly) as old as time. Fossil records have determined that the plant sprang up sometime in the middle of the Oligocene epoch, 34-23 million years ago, on the Tibetan Plateau, a region that is now home to Kazakhstan and Kyrgyzstan. One or more Neolithic groups likely domesticated it, and it traveled throughout Asia…
Cannabis access has expanded significantly in recent decades. Many states with medical programs have recently adopted recreational legislation allowing anyone 21 years and older to access the plant. This expanded access may leave you wondering if you should bother getting a medical card when you can just purchase cannabis from a recreational store. Medical and…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.